- Home
- BGLC vs INBS Comparison
BGLC vs INBS Comparison
Compare BGLC & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BGLC | INBS |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 5.7M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BGLC | INBS |
|---|---|---|
| Price | $2.18 | $2.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 61.3K | ★ 62.2K |
| Earning Date | 04-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.78 | ★ 68.65 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,424,911.00 | $1,980,484.00 |
| Revenue This Year | N/A | $778.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.07 | $0.54 |
| 52 Week High | $15.19 | $24.90 |
Technical Indicators
Market Signals| Indicator | BGLC | INBS |
|---|---|---|
| Relative Strength Index (RSI) | 44.82 | 36.96 |
| Support Level | $2.06 | $0.59 |
| Resistance Level | $2.29 | $2.46 |
| Average True Range (ATR) | 0.32 | 0.14 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 66.87 | 2.27 |
Price Performance
Historical ComparisonAbout BGLC BioNexus Gene Lab Corp
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.